PE Tech Report


Like this article?

Sign up to our free newsletter

RoundTable names Charles W. Stiefel senior adviser

RoundTable Healthcare Partners, a private equity firm focused exclusively on the healthcare industry, has appointed Charles W. Stiefel as senior adviser.

Stiefel will assist RoundTable in identifying investment opportunities, facilitating key industry introductions, and advising the firm on strategic and operational issues.

Stiefel is the former chairman of the board and chief executive officer of Stiefel Laboratories, the largest family-owned and operated dermatology company with nearly USD1bn in sales and 3,600 employees in over 100 countries. GlaxoSmithKline acquired Stiefel Laboratories for USD3.6bn in July 2009.

In 2003, Stiefel was awarded the Lifetime Achievement Award by the South Florida Dermatology Foundation, and in 2006 was named Ernst & Young’s Entrepreneur of the Year in Health Sciences for the State of Florida.

"We are extremely excited to have Charlie join the RoundTable team," says Jack McGinley, founding partner. "Charlie is a leader in the dermatology industry and is highly regarded by his peers. We admire his success of building a family-run company into an industry leader. We will benefit greatly from his extensive pharmaceutical experience, expertise and relationships."

Stiefel adds: "I am very pleased to be a part of the RoundTable team. I am impressed with the firm’s core values, culture, and highly successful track record in the pharmaceutical and medical device industries. RoundTable brings a real valued-added, operational approach which is unique. They bring resources and expertise to support their companies’ growth and achieve their strategic objectives. I look forward to working closely with RoundTable and assisting their efforts."

Like this article? Sign up to our free newsletter




Blackstone Private Equity